Havas Health Announces The Launch Of xigxag

NEW YORK, Sept. 28, 2015 /PRNewswire/ -- Havas Health is pleased to announce the launch of a new consultancy company, xigxag. Headed by partner Julie Monroid, who served as Havas Health's chief strategy officer and an agency leader for more than seven years, xigxag is supported by a proprietary Commercial Strategy System (framework, model and platform).

With a streamlined, efficient structure, xigxag will solve the problems that healthcare clients often face when working with traditional consultancy companies and advertising agencies, from struggling with vendors and not being set up for high-level analysis and recommendations, to not truly understanding the client's business and being unable to locate integrated, comprehensive, current data. A highly experienced team of strategists, analysts and operations staff will make sure xigxag's work is smart, correct and complete.

Monroid, managing principal of xigxag, explains: "We launched xigxag to deliver precise and pragmatic strategies focused on real-world execution, all with the end in mind. Comprising the industry's best thinkers, xigxag takes a different angle on strategic development in order to create unique approaches and solutions to optimize commercialization for our clients in the biopharma and healthcare industries."

Donna Murphy, global CEO of Havas Health, adds: "Julie Monroid is one of our network's genuine superstars, and we are committed to her vision of a next-generation consultancy that marries excellent insights into biopharma with high-level business analysis. She and her team incorporate strategy, analytics and operational expertise into a new approach to commercial strategy built around a patient flow framework, model and platform."

Ahead of its formal launch on Oct. 1, 2015, xigxag has formed a strategic partnership with Orbytel Group (formerly Abuwala & Company), led by Murt Abuwala, to support commercial analytics. Orbytel brings more than 30 years of consulting background and experience working in valuation (M&A), new product planning and corporate finance. They are experts in data science, decision analytics and predictive modeling.

In addition to new takes on traditional consulting services, xigxag's Commercial Strategy System includes a new patient flow framework, model and platform; a customer, decision-based segmentation analysis and tool; and a customer, channel and investment model. Coupling deep analytics capability with practical strategic smarts, xigxag offers clients new angles on strategy to become more effective with how they approach and execute commercialization.

About Julie Monroid
Julie Monroid has more than 15 years of healthcare experience. During those years, she has served many roles in agency services, from account services to management to strategy. As president of Havas Life New York (formerly Euro RSCG Life MetaMax), her firm was named Med Ad News Agency of the Year, Category II winner in 2009. In her most recent role as chief strategy officer of Havas Health, Monroid was responsible for building and operationalizing an industry-leading medical, planning and access strategic services offering. Her healthcare experience in more than 15 categories includes work with aesthetics, Alzheimer's disease, cholesterol, depression, diabetes, dry eye, erectile dysfunction, glaucoma, migraine, MS, overactive bladder, pain, pulmonary arterial hypertension, schizophrenia, severe sepsis, smoking cessation, thrombosis, ulcerative colitis, weight loss, wet AMD, women's health and vaccines. Monroid also has unique experience in health services and programs including specialty pharmacy, infusion services, lab testing and health systems. Her device/technology experience includes cardiac rhythm devices and services and a prescription diabetes management platform. Monroid's OTC experience includes detergent, dry eye, lens care and nutrition, and she has experience in patient support and value-add programs and offerings across cholesterol, diabetes, MS, overactive bladder and pain.

About Murt Abuwala
Murt Abuwala focuses on helping pharmaceutical and biotechnology companies reduce the time and costs required to bring products to market and making those products more successful when commercialized. He has been working in the pharmaceutical and biotechnology industry since 1998 and has had the privilege of working in different roles as scientist, technologist, sales and marketing executive, and consultant. Over this period, Abuwala has worked with nearly 30 publicly traded global biopharmaceutical companies including seven of the top 10 on strategic and operational issues within and across research, development, corporate development, corporate finance, product planning, medical affairs, marketing, sales, managed markets, distribution, trade, legal, information technology and regulatory affairs. His career began in enzyme kinetics (biochemistry) and transitioned to consulting, initially in strategy and then onto operations and systems. Subsequently, Abuwala joined a pre-IPO biotechnology company where he eventually became one of three commercial leads and helped it go public. Abuwala also led the commercial strategy and early commercialization consulting practices at two leading firms before starting Orbytel Group in 2009 (consulting services and technology solutions). Orbytel Group's flagship platform, harmony, was recently recognized as one of the most promising technology solutions in the industry. 

About Havas Health
Havas Health houses Havas Life (formerly Euro RSCG Life), Health4Brands (H4B) and Havas Lynx, three wholly owned health and wellness communication networks, and defines policies and processes for the global group. With more than 60 offices in 50 countries, the Havas Health network has a uniquely unified model offering strategy, promotion, medical education, market access, PR and digital solutions inside each agency asset. For more information about Havas Health, visit the company's website at havashealth.com.

CONTACT:
Lisa Vanella
Havas PR North America
917-602-7883
[email protected]

SOURCE Havas Health